Description of a pharmacist-led employee wellness hypertension program utilizing remote monitoring devices
Abstract
PURPOSE: The design, implementation, and impact of a pharmacist-led employee wellness hypertension program that utilizes remote blood pressure monitoring are described. SUMMARY: Employees of a private university and health insurance beneficiaries with a diagnosis of hypertension or a documented high blood pressure reading at a previous screening encounter were eligible to participate in the program. Participants received a remote blood pressure monitoring device and followed up with a pharmacist in person or via telehealth throughout the program. The pharmacist provided education on lifestyle modifications to improve blood pressure control, and recommendations regarding changes to the participant's medication therapy were made to the participant's primary care provider. Participants completed an in-person appointment at month 3 of the program for blood pressure reassessment. Twenty-four participants were enrolled in the program. The mean baseline systolic and diastolic blood pressures were 134 mm Hg and 85 mm Hg, respectively. Of the total of 24 participants, 18 participants (75%) had a blood pressure above their goal at baseline. At month 3 of the program, 7 of these 18 participants (39%) had achieved their blood pressure goal, with average systolic and diastolic blood pressure decreases of 8.9 mm Hg and 7.8 mm Hg, respectively. Pharmacist recommendations to primary care providers regarding medication changes had an acceptance rate of 70%. CONCLUSION: A pharmacist-led employee wellness hypertension monitoring program that utilized remote monitoring devices improved employee blood pressure control through education on lifestyle modifications and medication recommendations to the participants' primary care providers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Providers default to therapeutic inertia, failing to titrate medications despite receiving actionable physiological data.
“Consequently, providers default to therapeutic inertia, failing to titrate medications despite receiving actionable physiological data [7,8].”
Direct cellular-enabled peripherals eliminate localized network failure points but introduce higher recurring hardware and data subscription costs, presenting a trade-off between deployment reliability and financial scalability.
“Completely infrastructure-independent solutions, like direct cellular-enabled peripherals, eliminate these localized network failure points but introduce higher recurring hardware and data subscription costs, presenting a clear trade-off between deployment reliability and financial scalability [8].”
Clinical teams routinely experience alert fatigue, increased administrative workloads, and persistent therapeutic inertia when attempting to titrate medications based on remotely transmitted data.
“clinical teams routinely experience alert fatigue, increased administrative workloads, and persistent therapeutic inertia (delays in escalating treatment despite recorded clinical need) when attempting to titrate medications based on remotely transmitted data [7,8].”
Cites
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
The global epidemiology of hypertension
Mills, K. T., Stefanescu, A. R., & He, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0244-2 · Cited by 4,536 · see citing works
Margolis, K. L., Asche, S. E., Bergdall, A. R., Dehmer, S. P., Groen, S. E., Kadrmas, H. M., Kerby, T. J., Klotzle, K. J., Maciosek, M. V., Michels, R. D., et al. (2013) · JAMA · doi:10.1001/jama.2013.6549 · Cited by 591 · see citing works
Omboni, S., McManus, R. J., Bosworth, H. B., Chappell, L. C., Green, B. B., Kario, K., Logan, A. G., Magid, D. J., Mckinstry, B., Margolis, K. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15873 · Cited by 307 · see citing works
Clinical inertia in the pharmacological management of hypertension
Milman, T., Joundi, R. A., Alotaibi, N. M., & Saposnik, G. (2018) · Medicine · doi:10.1097/md.0000000000011121 · Cited by 140 · see citing works
Barriers to hypertension control
Borzecki, A. M., Oliveria, S. A., & Berlowitz, D. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.047 · Cited by 127 · see citing works
Implementing a home-based virtual hypertension programme—a pilot feasibility study
Gupta, A., Ellis, S. D., Burkhardt, C. D., Young, K. J., Mazzotti, D. R., Mahnken, J. D., Abu-el-rub, N., Chandaka, S., Comfort, B. W., Shanks, D., et al. (2022) · Family Practice · doi:10.1093/fampra/cmac084 · Cited by 16 · see citing works
Centrally supported clinical pharmacist intervention to reduce clinical inertia in hypertension
Lowe, R. N., Kovac, N., Lobo, I. E., & Billups, S. J. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac369 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Wu, M., Huang, X., Liang, C., Wang, P., Zhang, Y., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1640727 · Cited by 2 · see citing works
Gazda, N. P., Peek, G. K., Vest, T. A., Francart, S. J., & Eckel, S. F. (2026) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxag232
- Authors
- Gushrowski, M. N., Rush, M. J., Kier, K. L., & Hinson, J.
- Affiliations
- Ohio Northern University (US)
- Corresponding author
- Gushrowski, Megan N
- ORCID
- Kier, Karen L
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-04-10
- Volume
- 82
- Issue
- 22
- Pages
- 1265-1270
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W4409347031
- Cited by
- 3
- References
- 8
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Health-System Pharmacy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Keywords
- pharmacist intervention, employee wellness, hypertension, remote blood pressure monitoring, telemedicine, blood pressure control, health insurance beneficiaries, university employees
- MeSH terms
- Adult, Aged, Blood Pressure, Blood Pressure Determination, Female, Health Promotion, Humans, Hypertension, Male, Middle Aged, Occupational Health Services, Pharmacists, Telemedicine, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
